Buscador de publicaciones<< Volver
Cuadrado-Godia E, Munteis E, Martínez-Rodríguez JE, Pont-Sunyer C, Cucurella G, Roquer J
[Lipid profile evolution during the first year of treatment with beta interferon in multiple sclerosis].
Med Clin (Barc). 2009 Feb;132(7):259-61, PMID: 19248875
Treatment with beta interferon (IFNbeta) might alter the lipid profile. Plasmatic levels of total cholesterol and low density lipoprotein-cholesterol have been associated with the number of plaques in magnetic resonance of patients with demyelinating syndromes.
MEDICINE, GENERAL & INTERNAL
Una iniciativa de
